Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 30 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 9 | 384−6.4%/yr | −6.4%/yr | 3.81.2× | 13% | 320 in 2030−3.1%/yr |
| Lumbar fusion | 7 | 286+1%/yr | +1%/yr | 2.81.0× | 0% | 250 in 2030−2.3%/yr |
| Kyphoplasty & vertebroplasty | 4 | 184+3.2%/yr | +3.2%/yr | 1.81.3× | 0% | 210 in 2030+2.6%/yr |
| Cervical fusion & disc arthroplasty | 3 | 152−5.1%/yr | −5.1%/yr | 1.51.1× | 0% | 160 in 2030+0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 36 | 5,540+4.8%/yr | +4.8%/yr | 53.90.7× | 22% | 8,000 in 2030+6.3%/yr |
| Skin substitutes & wound grafts | 1 | 700+2.6%/yr | +2.6%/yr | 5.20.7× | 34% | 600 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 12 | 670−3.9%/yr | −3.9%/yr | 6.50.7× | 37% | 740 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 8 | 392−7.1%/yr | −7.1%/yr | 4.00.9× | 0% | 350 in 2030−1.8%/yr |
| Peripheral arterial intervention | 5 | 361−11%/yr | −11%/yr | 3.50.8× | 0% | 220 in 2030−8.1%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 126−1.2%/yr | −1.2%/yr | 1.30.9× | 0% | 260 in 2030+13%/yr |
| Carotid revascularization | 3 | 119−14%/yr | −14%/yr | 1.21.0× | 0% | 380 in 2030+21%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 7 | 627−1.4%/yr | −1.4%/yr | 6.61.1× | 0% | 580 in 2030−1.4%/yr |
| Cholecystectomy & appendectomy | 6 | 502−6.4%/yr | −6.4%/yr | 5.11.2× | 0% | 570 in 2030+2.2%/yr |
| Colorectal resection | 0 | 196−4.4%/yr | −4.4%/yr | 2.01.1× | 0% | 230 in 2030+2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 10 | 352−6.2%/yr | −6.2%/yr | 3.60.7× | 0% | 360 in 2030+0.5%/yr |
| BPH procedures | 10 | 315−10%/yr | −10%/yr | 3.10.7× | 15% | 340 in 2030+1.1%/yr |
| Hysterectomy, hysteroscopy & ablation | 1 | 216−1.3%/yr | −1.3%/yr | 2.30.8× | 10% | 220 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 1 | 132−10%/yr | −10%/yr | 1.30.4× | 16% | 180 in 2030+5.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 20 | 868+4.3%/yr | +4.3%/yr | 9.11.3× | 6% | 1,140 in 2030+4.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 12 | 1,926+24%/yr | +24%/yr | 19.10.7× | 48% | 3,400 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| LAA occlusion & loop recorders | 15 | 600+12%/yr | +12%/yr | 5.51.8× | 0% | 1,190 in 2030+12%/yr |
| Pacemaker, ICD & CRT implantation | 10 | 559−1.6%/yr | −1.6%/yr | 5.81.1× | 0% | 640 in 2030+2.2%/yr |
| EP ablation | 5 | 223+7.5%/yr | +7.5%/yr | 2.00.6× | 0% | 500 in 2030+15%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 17 | 1,001−4.7%/yr | −4.7%/yr | 8.81.5× | 0% | 1,160 in 2030+2.5%/yr |
| Structural heart (TAVR, TEER) | 13 | 293+12%/yr | +12%/yr | 2.61.5× | 0% | 520 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 23 | 8,264+1.9%/yr | +1.9%/yr | 82.01.2× | 78% | 9,110 in 2030+1.6%/yr |
| Vitreoretinal surgery | 2 | 184+6.1%/yr | +6.1%/yr | 1.90.8× | 73% | 130 in 2030−5.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 47 | 10,191−0.7%/yr | −0.7%/yr | 105.10.9× | 16% | 11,000 in 2030+1.3%/yr |
| ERCP & endoscopic ultrasound | 7 | 463+12%/yr | +12%/yr | 4.71.2× | 0% | 800 in 2030+9.4%/yr |
| Bronchoscopy & lung nodule | 6 | 329+11%/yr | +11%/yr | 3.30.9× | 0% | 750 in 2030+15%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.